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 Chapter 25 
 One Compartment Fermentation Model 
 Anna-Marja  Aura and  Johanna  Maukonen 
 Abstract  In vitro colon model was fi rst applied in an inter-laboratory dietary fi bre 
(DF) fermentation study and adapted at VTT for whole foods and beverages, iso-
lated dietary phenolic compounds and pharmaceuticals. The application of the 
 models includes strict anaerobiosis, which ensures active anaerobic microbial com-
munity. Pooling of faecal samples from several donors ensures reproducibility 
between the experiments. The correlation of in vitro data with in vivo data is quan-
titatively challenging, but is qualitatively highly relevant. In this chapter we explain 
the applicability of the one compartment fermentation model, including the general 
protocol as well as the advantages and disadvantages of the system. 
 Keywords  One compartment colon in vitro model •  Human faecal microbiota • 
 Anaerobic conditions •  Microbial metabolites •  Dietary fi bre •  SCFA 
25.1  Description of the VTT One Compartment 
Fermentation Model 
25.1.1  History of the Model 
 In 1995, VTT developed an enzymatic digestion model to simulate the digestion of 
DF in the upper intestine. The model was optimized for maximal starch digestion 
and to obtain non-digestible DF residue using physiological conditions (Aura et al. 
 1999 ). In the same year an inter-laboratory study of in vitro colon fermentation 
models was published by Barry et al. ( 1995 ). The physiological relevance of the 
model was ensured by a multidisciplinary approach involving specialists in nutri-
tion and gastroenterology. The fermentation was expressed as the difference 
between the faecal control (inoculum, no substrates) and substrates under investiga-
tion (e.g. plant foods or other DF ingredients). Later the model was adapted for pure 
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phenolic compounds (Aura  2005 ), fruit matrices and beverages (Bazzocco et al. 
 2008 ; Aura et al.  2013 ). The fermentation model from Barry et al. has been used in 
combination with the enzymatic digestion model from Aura et al. ( 1999 ) for cereal 
studies ( Nordlund et al.  2012 ,  2013 ). Most recently the model has been coupled to 
a platform with bioinformatics tools to obtain non-targeted metabolite profi ling of 
plant foods (Aura et al.  2013 ). 
25.1.2  Special Features 
 Venema and van den Abbeele ( 2013 ) have pointed out recently a non-physiological 
slow rate of conversion in “static cultures”. In reference to the unit operation the 
authors describe the “static” culture conditions (in contrast to the continuous 
“dynamic” culture conditions) (Venema and van den Abbeele  2013 ) often in context 
of one compartment cultures. When one compartment in vitro colon models are per-
formed in well-buffered non-nutrient media with strictly anaerobic microbiota, accu-
rately timed sampling and monitoring of pH changes, they appear to show also the 
distinctively higher rate of conversion. The time course studies under agitation bring 
out the dynamic processes, which occur from food components also in “batch” unit 
operations. Static, standing cultures without agitation cannot be used in conversions 
related to DF components or isolated phenolic compounds, because the suspension 
would sediment and enzyme–substrate interaction would be suppressed, especially 
in incubations with solid substrates such as DF components. 
 A distinctive characteristic of the VTT one compartment in vitro colon model is 
the use of a strong buffer with minerals as the main matrix of the medium (Barry 
et al.  1995 ) instead of nutritive medium with additional carbon sources (Hughes 
et al.  2008 ). The faecal material brings additional carbohydrates and a matrix to 
support the microbiota together with the buffer and mineral solution. It has been 
shown in previous studies (McBurney and Thompson  1989 ; Mortensen et al.  1991 ) 
that use of faeces from at least three donors secures the diversity of the microbiota 
and enables the reproducibility of the results. Therefore in the one compartment 
in vitro model applied at VTT a pooled human faecal suspension is prepared from 
samples from at least 3 but usually from 4 to 6 donors. 
 The faecal inoculum is dense (10–16.7 %, w/v), especially, when non-digestible 
carbohydrate fermentation is performed. The microbiota acts as a source of enzymes, 
which degrade and convert released components such as sugars to short-chain fatty 
acids (SCFA) or phenolic compounds to microbial phenolic acid or lactone 
metabolites. 
 One of the positive features of the VTT model is that the anaerobic conditions 
can be easily maintained as the system is closed and air-tight. This anaerobic envi-
ronment is needed to avoid damaging of the strictly anaerobic microbiota during the 
preparation of the inoculum (homogenization, dilution and fi ltration) and its 
 incubation with substrates. It also ensures that the microbial enzymes can perform 
degradation of DF constituents under the same conditions as in the human gastroin-
testinal tract. 
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 The quality of the anaerobic conditions in the VTT model was tested by cultivating 
samples from the fresh faecal suspension in aerobic and in anaerobic conditions and 
counting the microbial cells after the cultivation. The initial (0 h) anaerobic cell 
count (1.6 × 10 9 CFU/ml) exceeded that from the corresponding aerobic cell count 
(3.1 × 10 7 CFU/ml). After 4 h of anaerobic incubation at 37 °C, cell counts were 
changed to 3.2 × 10 9 CFU/ml and 2.3 × 10 7 CFU/ml, for the anaerobic and aerobic 
cell counts, respectively. The corresponding log 10-anaerobic-to-aerobic ratios 
were 1.2 and 1.3 for 0 h and 4 h, respectively, indicating that anaerobic conditions 
were not disturbed during the incubation. When frozen faeces were used as an inoc-
ulum in three experiments, the log 10-anaerobic-to-aerobic ratio was 1.5 ± 0.2, but 
cell counts were 10 % of the fresh inoculum. After 4 h in corresponding conditions 
both the cell counts showed fourfold increase, and the log 10-anaerobic-to-aerobic-
ratio was still 1.3 ± 0.04. Based on these results it was concluded that fresh inoculum 
was the most vital for DF fermentations and that the inoculum preparation condi-
tions need to be strict enough for maintaining the adequate difference between the 
anaerobic and aerobic microbiota (2–3 log difference). When the cultivated 
log 10-anaerobic-to-aerobic ratio is between 1.2 and 1.6, anaerobic microbiota 
dominates the population. If the ratio were 1, strictly anaerobic strains would 
be dead and only microaerophilic strains would stay alive. This would be non- 
physiological situation in terms of DF fermentations. 
 Faecal samples from each donor and the corresponding faecal suspension were 
obtained from the in vitro colon model and kept frozen at −70 °C before microbio-
logical analysis. Partial 16S rRNA gene was amplifi ed for the denaturing gradient 
gel electrophoresis (DGGE) analysis of predominant bacteria,  Eubacterium rectale –
 Blautia coccoides group (Erec-group,  Lachnospiraceae ),  Clostridium leptum group 
(Clept-group,  Ruminococcaceae ),  Bacteroides ,  Bifi dobacterium and  Lactobacillus 
as previously described (Maukonen et al.  2006 ,  2012 ). Above mentioned bacterial 
profi les of individual donors were compared to the bacterial profi les of the corre-
sponding faecal suspension. Even though the inter-individual similarity between the 
donors was low (Fig.  25.1 ), and partly different people were used as donors in dif-
ferent in vitro colon model experiments, the bacterial profi les of faecal suspensions 
were rather similar (Fig.  25.2 ). In predominant bacteria, Clept-group, lactobacilli 
and bifi dobacterial profi les clear differences between faecal suspensions were 
observed. However, the observed differences corresponded to intra-individual 
 temporal variation previously observed in healthy adults (Maukonen et al.  2012 ). 
Moreover, in the Erec-group (Fig.  25.2b ) and in  Bacteroides profi les there were no 
major differences between the different faecal suspensions. Erec-group bacterial 
populations have also previously been shown to be temporally rather stable 
(Maukonen et al.  2006 ). 
 In conclusion, the microbiological reproducibility of the in vitro model was 
good: the microbiological variation observed between the different in vitro colon 
model experiments was equivalent to intra-individual temporal variation. Since 
DNA-based methods were used, which target both living and dead bacteria, it can-
not be reliably stated that the active microbiota has been the same in each experi-
ment. The used DGGE methods target only the rDNA amplicons obtained from the 
population that exceeds 1 % of the species present in the analysed community 
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(Muyzer et al.  1993 ), therefore our results show that the most dominant bacteria 
within each bacterial group were similar. This study of microbiological reproduc-
ibility was a quality measure, which ensures that the metabolites are less dependent 
on the microbiota than from the substrates. Other microbial ecological studies are 
not recommended with the one compartment in vitro colon model, since the model 
is designed to study microbial metabolism of various substrates and for comparison 
of their metabolite dynamics. 
 Fig. 25.1  Bifi dobacterial 
profi les of samples used for 
in vitro fermentation 
(BM = bifi dobacterial marker; 
A–C = donors; 3 = faecal 
slurry) 
 Fig. 25.2  Predominant bacterial ( a ),  Eubacterium rectale – Blautia coccoides group ( b ),  Clostri-
dium leptum group ( c ) and  Bifi dobacterium ( d ) DGGE-profi les of faecal slurries used for fi ve (1–5) 
different in vitro fermentations.  Red arrows denote clear differences between samples 
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25.2  Validation of the System 
 The validation of the model was performed by comparing the variability of meta-
bolite concentrations in the faecal control (inoculum, no substrates) and in the sub-
strate incubation in experiments performed on different days. The faecal control 
measurement provided information on the variation of the background fermentation 
of the remaining fermentable carbohydrates or phenolic compounds from the diet of 
the faecal donors. Table  25.1 shows comparison of 4 or 5 experiments in respect to 
major microbial metabolites and pH in the faecal control at 0-h- and 24-h-time 
points. The smaller the response, the higher is the variation of the response. The 
variation is smallest (14–25 %) for total SCFA, acetic acid, propionic acid and 
3-phenylpropionic acid, whereas butyric acid varies 21–37 % between the experi-
ments. pH shows only 1–2 % variation, for the initial pH 5.5 of the buffer; and 
3-hydroxyphenylpropionic and -acetic acids show 65–114 % (0 h) and 23–27 % 
(24 h) variations. Furthermore, when the concentrations of the metabolites in the 
faecal control are compared between the experiments, the differences are dependent 
on the metabolite and its dynamics and particularly the diets of the donors of the 
faeces. The differences are balanced by pooling the inoculum from several donors. 
Therefore, the major phenolic metabolites in the in vitro model show similar variation 
between experiments (65–114 %) in phenolic microbial metabolites than corre-
sponding urinary excretion profi les shown between different human individuals 
(70–113 %) (Vetrani et al.  2014 ).
 The true validation requires the same reference substrate for all experiments 
under investigation. Usually the space in the experiment is limited and the reference 
substrate is chosen according to the hypotheses of the specifi c projects. Rye bran 
and fl axseed meal were used in several experiments, the responses were measured 
 Table 25.1  Variation of different microbial metabolites (mean ± standard deviation) measured 
from the faecal control between experiments (n: number of experiments) in the beginning (0 h) and 
in the end (24 h) of the incubation 
 Response  0 h  24 h  n  References 
 Total SCFA (mM)  11.7 ± 2.6  32.6 ± 5.7  5  1 
 Acetic acid (mM)  7.6 ± 1.5  20.5 ± 4.5  5  1 
 Propionic acid (mM)  1.7 ± 0.3  5.9 ± 1.1  5  1 
 Butyric acid (mM)  2.4 ± 0.9  6.2 ± 1.3  5  1 
 pH (initial 6.9) (range) 
 pH (initial 5.5) 
 6.99–7.07 
 6.07 ± 0.05 
 6.67– 6.68 




 3-Hydroxyphenylpropionic acid (μM)  7.7 ± 3.5  7.3 ± 2.4  3  2 
 3-Phenylpropionic acid (μM)  96 ± 15  235 ± 71  3  2 
 3-Hydroxyphenylacetic acid (μM)  5.4 ± 4.4  8.7 ± 1.7  3  2 
 1: Nordlund et al. ( 2012 ), Bazzocco et al. ( 2008 ), Aura et al. ( 2013 ) and Nordlund et al. ( 2013 ) 
 2: Aura et al. ( 2013 ) and Bazzocco et al. ( 2008 ) 
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as SCFA production and were summarized in Aura ( 2005 ). The total SCFA  formation 
at the end of the fermentation showed 10 % and 18 % variations for  enzymatically 
pre-digested rye bran (83.3 ± 8.5 mM, n = 4) and pre-digested fl axseed meal 
(95.3 ± 17.5 mM, n = 3), respectively. Taking into account the different inoculum 
concentrations (10 % or 16.7 %) used in these studies, the variation was surprisingly 
low for SCFA production. In contrast, the 97 % variation of the enterolactone for-
mation from predigested fl axseed meal (43 ± 42 nM, n = 3) was highly dependent on 
the inoculum concentration. This could be explained by the minor population 
of enterolactone-converting bacteria (Clavel et al.  2005 ) and therefore the extent of 
conversion was susceptible to the depletion by the low concentration of inoculum. 
Furthermore, the resilient structure of fl axseed meal and low nano-molar concentra-
tions may have contributed to the high variation (Aura  2005 ). 
25.3  Relevance to Human In Vivo Situation 
 The one compartment in vitro colon model measures only those conversions, which 
occur in anaerobic conditions by faecal microbiota. These reactions take place in cae-
cum prior to absorption. The model does not take into account the membrane func-
tions which occur in the colon epithelia, the intestinal epithelia and in the liver. The 
major metabolites from the DF intake are SCFA and phenolic microbial metabolites. 
The major SCFA formed in the colon is acetic acid, which does not have distinctive 
structural characteristics, which would be needed for follow-up of its route without a 
radiolabel. For example a correlation was sought for SCFA production between a fi bre 
blend and its components in vivo and in vitro (Koecher et al.  2014 ). In vitro experi-
ments showed SCFA formation and analysis of SCFA from faeces revealed an increase 
of SCFA content in faeces after consumption of the fi bre blend versus fi bre free 
diet, however, signifi cant differences between the ingredients of the blend were not 
observed in vivo (Koecher et al.  2014 ). The authors speculated about the balance 
between production and absorption rates of microbial metabolites and concluded that 
the in vivo interventions and in vitro studies may not be directly correlated, but in vitro 
models are additionally informative (Koecher et al.  2014 ). 
 Phenolic compounds and their microbial metabolites may be better biomarkers 
for plant food and dietary fi bre intake than SCFA. The metabolites in urine include 
also membrane-derived metabolites, such as glucuronidated and sulfated deriva-
tives of phenolic compounds. In addition to this urine contains the microbial metab-
olites derived from the diet (Aura  2008 ). The closest and most non-invasive measure 
is the analysis of 24-h-urine, which describes the excretion of metabolites from 
the food and beverage intakes (Vetrani et al.  2014 ). The fi rst challenge is that the 
urinary analysis describes the excretion of the metabolites from the whole diet from 
several precursors (Vetrani et al.  2014 ) which share the microbial metabolites (Aura 
 2008 ). If the diet is not controlled the background can be disturbed by the excretion 
of phenolic metabolites from the non-controlled components, and statistical differ-
ences are not obtained (Lappi et al.  2013 ). 
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 Another issue is that a single component does not change the excreted  metabolites 
in a signifi cant way (Lappi et al.  2013 ), whereas a fully controlled diet high or low 
in polyphenols can show signifi cant metabolite profi les typical for the polyphenols 
(Vetrani et al.  2014 ). Therefore, the metabolites cannot be connected to a single food 
or component, but refer to a whole diet. The third challenge is that the comparison 
of in vivo responses match qualitatively well with the microbial metabolites expected 
to be excreted from the food phenolic components (Aura  2008 ; Lappi et al.  2013 ; 
Vetrani et al.  2014 ). However, quantitative comparisons are problematic because of 
the high individual variation of microbial metabolites in vivo (Vetrani et al.  2014 ) 
and the diversity of hepatic metabolites, the quantifi cation of which requires unavail-
able authentic standards for most of them for signifi cant correlation. 
25.4  Quality in Relation to Other Models 
with the Same Applicability 
 When microbial metabolism of rutin (quercetin-rhamnoglucoside) and chlorogenic 
acid was studied in a one compartment fermentation model using four individual 
donors (Rechner et al.  2004 ), the patterns of the metabolite formations varied 
according to the subject. The formation of 3,4-dihydroxyphenylacetic or -propionic 
acid from rutin and chlorogenic acid, respectively, showed maxima at 8–10 h using 
10 % (w/v) suspension (Rechner et al.  2004 ). In contrast, using the diluted suspen-
sion (5 %, w/v) pooled and homogenized under strict anaerobic conditions, the 
corresponding value was shown in 2 h and complete dehydroxylation was observed 
in 8 h ( Aura et al.  2002 ). The inoculum in VTT one compartment system has to be 
diluted 1 % in order to observe the deglycosylation of quercetin derivatives or 
anthocyanins in different experiments (Aura  2005 ). It is likely that strict application 
of anaerobic conditions enables faster conversions, when vulnerable anaerobic 
microbial suspension is used as a source of activity. 
 When in vitro colon models using monogastric pig and human faeces as inocula 
were compared, human inoculum showed more effi cient fermentation for several 
sources of DF, whereas pig inoculum was more effi cient in cellulose digestion. The 
pig inoculum produced less SCFA and more gas compared with the human inocu-
lum. These differences were attributed to an adaptation of human microbiota to a 
more diverse diet compared to the pig feed and an adaptation of pig microbiota to 
a cellulose-rich diet (Jonathan et al.  2012 ). 
25.5  General Protocol 
 The latest description of the model is from Nordlund et al. ( 2012 ). In vitro colon 
model for measurement of SCFA and phenolic acids was started by weighing 
100 mg per 10 ml of incubation suspension (dry w/v) of plant foods or their 
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fractions to the bottles, and hydrating with 20 % of the volume of medium 1 day 
before inoculation. Human faeces were collected from at least 3 (usually from 4–6) 
healthy volunteers, who had not received antibiotics for at least 6 months and had 
given a written consent. Freshly passed faeces were immediately taken in an anaer-
obic chamber or closed in a container with an oxygen consuming pillow (Anaerocult 
Mini; Merck, Darmstadt, Germany) and a strip testing the anaerobiosis (Anaerotest; 
Merck, Darmstadt, Germany). Faecal suspension was prepared under strictly anaer-
obic conditions. Equal amounts of faecal samples were pooled and diluted to a 
12.5 % (w/v) or 20.8 % (w/v) suspension, depending on the application and 80 % of 
the volume of the incubation suspension was dosed to the fermentation bottles to 
obtain a 10 % or 16.7 % (w/v) fi nal faecal concentrations as described previously 
(Aura  2005 ). Lower concentrations can be used. For example 5 % suspension is 
suitable for isolated components, because the metabolite responses from faecal con-
trol are high in more dense inoculum and the substrate concentration should be 
below the saturation point of the substance to keep the substrate in the solution and 
not to suppress the activity of the microbiota. 
 The fermentation experiments were performed in triplicate and a time course of 
0, 2, 4, 6, 8 and 24 h is followed using the same inoculum for all the substrates. 
Incubation is performed at 37 °C in tightly closed bottles and in magnetic stirring 
(250 rpm). Faecal background is incubated without addition of the supplements 
(Aura  2005 ). Headspace is sampled for the measurement of gas pressure (Nordlund 
et al.  2012 ) and the liquid space is sampled for SCFA and phenolic acid metabolite 
analyses (Nordlund et al.  2012 ; Aura et al.  2013 ). 
25.6  Controls: Positive and Negative 
 Monitoring of metabolite background in the faecal control without substrate is 
 crucial. In addition to this it is recommendable to use inactive microbiota as a nega-
tive control (Aura  2005 ). Relevant reference compounds/ingredients should be 
used. For instance when fermentation rate is the focus of the study, reference sub-
strates such a “rapid” or “slow” standards can be used to make comparisons between 
different experiments. The controls should also be performed at least in three repli-
cates for adequate statistical evaluation. 
25.7  Read Out of the System 
 The read out of the in vitro colon model is caused by the interaction between micro-
bial enzymes and the precursors and expressed as time course of metabolite forma-
tion. The precursors can be carbohydrates and the products are then SCFA or gas 
formation (Nordlund et al.  2012 ). Other precursors can be fl avonoids, proanthocyani-
dins or plant-derived phenolic acids (ferulic acid, chlorogenic acid), which lead to 
the formation of benzoic acid derivatives or of hydroxylated phenylpropionic, -acetic 
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or -valeric acids (Aura  2008 ; Aura et al.  2013 ; Nordlund et al.  2012 ). Plant lignans 
are the precursors for enterodiol and enterolactone (the enterolignans) (Heinonen 
et al.  2001 ) and isofl avonoids for equol or O-desmethylangolensin  production 
(Heinonen et al.  2004 ; Possemiers et al.  2007 ). Furthermore ellagitannin conversion by 
intestinal microbiota results in formation of urolithins (Cerda et al.  2004 ). 
 The responses should be compared always within the experiment, using the ade-
quate number of intermediary time points, at least in triplicates and in respect to the 
inoculum, the responses of which is dependent on the diet of the donor. Moreover, 
the quantitative results should not be extrapolated between experiments and the 
responses should be related to the clearly indicated faecal control read out within 
the experiment. Thus the accepted microbial metabolite can only be one which 
shows at least two- to fi vefold higher responses than the background metabolites 
from the faecal control. Therefore the results show specifi c metabolite profi les from 
each substrate. These semi-quantitative results can be obtained from non-targeted 
metabolomics platform for identifi cation of new metabolites. Quan ti tative measures 
are achieved using the targeted approach, which limits the profi ling to those metab-
olites, which are available as authentic standards. A unit to be measured should be 
on molar basis, because structural transformations affect the molar masses and 
responses based on weight are not comparable. 
 The one compartment colon model can be applied to comparison of fermentation 
rates of different sources of DF or ingredients having different characteristics (Kaur 
et al.  2011 ; Koecher et al.  2014 ), whereas changes in microbial population requires 
a semi-continuous unit operation (Hughes et al.  2008 ). 
25.8  Summary of Advantages, Disadvantages 
and Limitations of the System and Contingency Plan 
 Table  25.2 summarizes the advantages, disadvantages and limitations of the one 
compartment in vitro colon model and is divided into characteristics of the opera-
tion of the model (unit operation, microbiota, anaerobiosis, pH monitoring and 
 control, timing and sampling, stirring) and into those of the outcome (data analysis, 
comparison of substrates, prediction of human metabolism, and absorption). It is 
important to judge the limitations in context of the hypotheses that are studied in the 
one compartment model.
 In conclusion, the one compartment fermentation model experiments perhaps do 
not mimic human pH changes or include absorption as the computer-controlled 
continuous models do, but the one compartment incubations are very suitable when 
the perspective is in the food matrix or its chemistry. In vitro colon models do not 
have membrane functions required for full mimicking of the xenobiotic metabo-
lism. However, in vitro one compartment digestion models explain the effects of 
food matrix on release of components or bioconversion of food components to their 
microbial metabolites and they can elucidate factors affecting these processing and 
predict in vivo bioavailability. This fi eld of food biochemistry is essential to eluci-
date phenomena, by which food chemistry turns into nutrition. 
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